Long-acting preparations also include semaglutide (SMG), dulaglutide (DUL), long-acting release formulation of exenatide (EX-LAR), and polyethylene glycol loxenatide (PEX-168), which generally need to be injected once a week
May 21, 2026
If evoke/evoke+ were to confirm such an effect size, it would position semaglutide as a novel modality offering several potential advantages over anti-amyloid therapies such as Lillys donanemab, e.g., oral formulation, simpler diagnostics, likely no need for PET scan monitoring
Any retatrutide available outside of clinical trials is sourced from research suppliers and has not undergone regulatory review
Theyre often produced in unregulated facilities without sterility testing, with no quality control on active ingredient concentration
Each formulation is personalized to align with your goals, physiology, and wellness journey